NCT04034862View on ClinicalTrials.gov

Impact of DOlutegravir+Lamivudine Simplification on HIV-1 Reservoirs

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

March 1, 2023

Study Completion Date

June 30, 2023

Conditions
HIV Infections
Interventions
DRUG

Treatment simplification (dolutegravir lamivudine)

Switch from 3 drug regimen (DTG/ABC/3TC) to 2 drug regimen

Trial Locations (1)

4000

Liège university hospital, Liège

All Listed Sponsors
lead

University of Liege

OTHER

NCT04034862 - Impact of DOlutegravir+Lamivudine Simplification on HIV-1 Reservoirs | Biotech Hunter | Biotech Hunter